Anika Therapeutics Inc. of Bedford, MA at MEDICA 2019 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option

Anika Therapeutics Inc.

32 Wiggins Avenue, 01730 Bedford, MA
USA

This company is co-exhibitor of
Messe Düsseldorf North America

Hall map

MEDICA 2019 hall map (Hall 16): stand F29-11

Fairground map

MEDICA 2019 fairground map: Hall 16

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.05  Implants and protheses
  • 01.05.03  Orthopaedic implants and prostheses
  • 05  Commodities and Consumer Goods
  • 05.15  Wound care equipment
  • 05.15.07  Wound covering / skin substitutes

Wound covering / skin substitutes

Our products

Product category: Orthopaedic implants and prostheses

One-Injection Combination Hyaluronic Acid and Steroid

CINGAL is the first and only approved combination viscosupplement formulated to provide the benefit of a cross-linked hyaluronic acid (HA) and a fast acting steroid to effectively treat the symptoms associated with osteoarthritis (OA).

CINGAL is a powerful, first-in-class treatment that combines the benefits of Anika’s proprietary cross-linked hyaluronic acid formulation of MONOVISC®, proven to deliver up to 6 months of relief of the symptoms of OA, with a well-established FDA-approved steroid to treat inflammation and provide additional short-term pain relief.1

CINGAL is Anika Therapeutics’ third-generation viscosupplementation product, adding to the Company’s strong product portfolio for the treatment of joint pain associated with OA.1 CINGAL extends the benefits of Anika’s proprietary HA formulation to a broader range of patients across the spectrum of osteoarthritis management.

More Less

Product category: Orthopaedic implants and prostheses

A One-Injection OA Treatment

MONOVISC is a single injection viscosupplement utilized to treat the joint pain caused by osteoarthritis. It is comprised of highly purified, partially cross-linked sodium hyaluronate (NaHA) in a phosphate buffered saline solution, and it is both biocompatible and resorbable.

With just one injection, MONOVISC may provide pain relief that lasts for up to 6 months.1

MONOVISC is the only non-animal sourced hyaluronic acid (HA) single injection treatment approved for use in the United States, and it delivers the maximum dose of HA (88mg) currently available in any single injection treatment.

More Less

Product category: Orthopaedic implants and prostheses

ORTHOVISC®-T: An Injectable Viscoelastic Sodium Hyaluronate

ORTHOVISC-T is an ultra-pure, high molecular weight injectable hyaluronic acid (HA) viscosupplement designed to relieve pain and restore function to tendons damaged by chronic tennis elbow. ORTHOVISC-T provides lubrication to promote tendon gliding, creating a beneficial healing environment.

ORTHOVISC-T is provided in a single-use syringe, and is injected around the affected osteotendinous junction once a week for a total of two injections.

More Less

About us

Company details

We are Anika Therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. We are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. With over 30 million procedures performed in the past twenty-five years utilizing our proprietary technology, Anika is helping individuals all over the world return to life naturally.

More Less